Aspirin and Preeclampsia Prevention in Patients With Abnormal Uterine Artery Blood Flow
Open Access
- 5 August 2014
- journal article
- Published by DoNotEdit in Iranian Red Crescent Medical Journal
- Vol. 16 (16) , e17175
Abstract
Background: Preeclampsia is one of the leading causes of maternal mortality and morbidity. Its prevalence varies between 10-25% among high-risk pregnant patients. Objectives: The aim of this study was to determine whether treatment with acetylsalicylic acid (ASA) reduces the incidence of preeclampsia among pregnant women with abnormal uterine artery flow. Patients and Methods: In this double-blind, placebo controlled trial, 80 high-risk pregnant women with preeclampsia, who had abnormal findings on Doppler ultrasonography at 12-16 weeks of pregnancy (unilateral notch with RI ≥ 0.65 or bilateral notch with RI ≥ 0.55), were randomly divided into two groups; the intervention group was treated with ASA tablet 80 mg, one tablet per day, and the control group was given placebo. Then patients were followed until the end of their pregnancy period, and pregnancy outcomes, including development of preeclampsia, the intrauterine growth retardation (IUGR), prematurity, type of delivery, birth weight, and Apgar score at one and five minutes were assessed. Data were analyzed using the student's t-test, chi-square or Fisher's exact test, and multivariate logistic regression. P values less than 0.05 were considered statistically significant. Results: There were no significant differences between the two groups in terms of baseline characteristics. There was a significant difference between the ASA and placebo groups in the incidence of preeclampsia (2.5% versus 22.5%), adjusting for the neonatal and maternal covariates. Conclusions: ASA prophylaxis can be used for prevention of preeclampsia in high-risk patients with abnormal uterine artery. Keywords: Pre-Eclampsia; Blood Flow; Prevention; ASAKeywords
This publication has 34 references indexed in Scilit:
- Early Administration of Low-Dose Aspirin for the Prevention of Severe and Mild Preeclampsia: A Systematic Review and Meta-AnalysisAmerican Journal of Perinatology, 2012
- Low-dose aspirin and preeclampsia preventionJournal of Postgraduate Medicine, 2011
- Antiplatelet agents for preventing pre-eclampsia and its complicationsCochrane Database of Systematic Reviews, 2007
- Severe maternal morbidity in Canada, 1991-2001Canadian Medical Association Journal, 2005
- Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected populationUltrasound in Obstetrics & Gynecology, 2005
- Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery DopplerPrenatal Diagnosis, 2005
- Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestationUltrasound in Obstetrics & Gynecology, 2001
- Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertensionThe Lancet, 1990
- Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced HypertensionNew England Journal of Medicine, 1989
- Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.BMJ, 1989